top of page
Oncology.jfif

Oncology & Radiopharmaceutical Execution

Integrated Oncology Execution Within Clinical Practice

Research Management Partners (RMP) is actively expanding its oncology capabilities through an embedded clinical model that integrates hemato-oncology and radiation oncology within active patient care environments.

Our approach is designed to support the execution of complex oncology trials, where coordination, precision, and real-time oversight are critical to study success.

A Model Built for Modern Oncology Trials

Oncology studies—particularly those involving targeted therapies and radiopharmaceuticals—require more than site availability.

They require:

  • Coordinated multidisciplinary care

  • Structured patient identification

  • Integrated imaging and treatment workflows

  • Strict protocol adherence under real-world clinical conditions

RMP addresses these demands by embedding research operations directly within oncology-capable practices—ensuring that execution occurs where patient care is delivered.

Clinical Leadership

Dr. Serguei Castaneda, MD
Head of Oncology – Research Management Partners (RMP)

Dr. Castaneda is a Radiation Oncologist and Internal Medicine physician with extensive experience across oncology clinical trials, including radiopharmaceutical and targeted therapy programs. His background includes clinical exposure within Harvard-affiliated institutions and the management of complex oncologic patient populations.

He leads the integration of oncology capabilities across RMP’s network, ensuring alignment between clinical care, study protocols, and operational execution.

Oncology Capabilities

RMP supports oncology studies through an integrated infrastructure designed for precision-driven research:

  • Hemato-oncology and radiation oncology integration

  • Multidisciplinary coordination across oncology teams

  • Support for advanced imaging and treatment workflows

  • Biomarker-driven patient identification and enrollment

  • CNS involvement monitoring and complex case management

  • Readiness for targeted therapies and radiopharmaceutical protocols

Radiopharmaceutical Trial Readiness

RMP is positioning its network to support the growing demand for radiopharmaceutical clinical trials, where coordination between imaging, treatment delivery, and patient monitoring is essential.

Our embedded model enables:

  • Alignment between clinical teams and protocol-specific workflows

  • Structured coordination of imaging and therapeutic procedures

  • Real-time oversight of protocol execution

  • Integration with specialized partners supporting radiopharma logistics

Biospecimen & Laboratory Integration

RMP collaborates with established laboratory partners with over 15 years of experience in biospecimen collection, processing, and storage.

This supports:

  • Protocol-specific sample collection and handling

  • Chain-of-custody control and real-time tracking

  • Integration with biomarker-driven study designs

  • Support for translational and precision oncology programs

Execution That Supports Oncology Outcomes

Oncology trials demand precision—not only in therapy, but in execution.

RMP’s embedded clinical model ensures that:

  • Study protocols are executed within real clinical environments

  • Patient pathways are aligned with research requirements

  • Data quality and protocol adherence are maintained in real time

This reduces variability, strengthens oversight, and supports consistent delivery across oncology studies.

When Sponsors Engage RMP for Oncology

Sponsors and CROs typically engage RMP when:

  • Oncology trials require stronger site-level execution

  • Enrollment depends on precise patient identification

  • Protocols involve complex workflows or multidisciplinary care

  • Radiopharmaceutical or targeted therapy studies require integrated environments

  • Execution consistency across sites is critical

Call to Action

Advance Your Oncology Program with RMP

If your study requires structured execution, integrated clinical environments, and real-time oversight, RMP is positioned to support your oncology development strategy.

                        Request an Oncology Capability Discussion
                                        admin@rmpsmo.com

                                            786-464-0868

                                     Response within 48 hours

bottom of page